Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

PHARMACIST - BCPA: 2020 ADA Updates


Date: Feb 26, 2020 07:00 PM - 07:45 PM

Location: UIW Feik School of Pharmacy, 703 E. Hildebrand, San Antonio, TX, 78212

CE Hours

1.00

CE Units

0.100

Registration closes on Apr 08, 2020 11:55 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

 
 
 
 
 
Accreditation Council for Pharmacy Education
The University of the Incarnate Word Feik School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
 
 
 
 

Joint Provider(s)

Bexar County Pharmacy Association (BCPA)

Requirements for CE Credit

  • The participant will only receive credit for programs after receiving a 70% on a post-test and an evaluation form is completed and submitted. 
  • The entire session must be attended to receive credit. No partial credit will be given. 
  • Certificates will not be mailed. Contact hours will be uploaded to NABP's CPE Monitor after successful completion of post-test and program evaluation. 
  • To receive credit, participant profiles must contain a valid NABP e-profile ID number and month/date of birth. 
  • All requirements to receive credit must be completed within six weeks of participation in the CPE program. Failure to complete requirements within the six-week window will result in no credit awarded to the participant. 

Please choose a Fee Type from the Drop Down Menu Below:
I am a
 

 

Registration closes on Apr 08, 2020 at 11:55 PM

Registration Closed  

Upon completion of this activity, participants will be able to:
  1. Identify the changes in goals and treatment recommendations presented in the 2020 ADA guidelines.
  2. Describe the new treatment options available for diabetes mellitus.
  3. Discuss evidence-based treatment options that optimize glycemic, cardiovascular, and renal outcomes in patients with type 2 diabetes mellitus.
  4. Compare and contrast the available treatment options in light of available safety, efficacy and outcome data.
 
 

Speaker(s)/Author(s)

Christine Lam

Activity Number

0445-9999-20-005-L01-P
Date: 02/26/20
Time: 07:00 PM - 07:45 PM

CE Hours

1.00

Location

FSOP 533 (P3 Classroom)
Registration Closed